Table 2. Guidelines in developed countries recommending routine antibody screening during pregnancy.
Countries | Prevalence of red cell antibodies/ alloantibodies other than anti-D (Ref.) |
Recommendation (Ref.) |
---|---|---|
Netherlands | 1.23%/0.32% (5) | ABO, Rh(D) and Rh(c) blood group antigen typing and screening for RBC antibodies at the booking visit and again at week 27 (16). |
United Kingdom | 1%/0.3% (17) | ABO, Rh(D) and Rh(c) blood group antigen typing and screening for RBC antibodies at the booking visit and again at week 28 (14). |
Australia & New Zealand | 0.73%/0.65% (18) | ABO, Rh(D) blood group antigen typing and screening for RBC antibodies at the booking visit (19). |
United States | 0.3-3.4%/0.74% (20) | ABO, Rh(D) blood group antigen typing and screening for RBC antibodies at the booking visit (21). |